Latest From Biotech Now

A Bright Future for Orphan Disease Indications

Chart

In celebration of National Rare Disease Day BIO’s Industry Analysis team took a look at recently-approved drugs in the BioMedTracker database with an orphan indication designation. Our research found that 2012 saw the greatest number of approvals of therapies for orphan indications going back all the way to 2000 (This count includes previously approved drugs with new, orphan indication approvals).   Overall, 24 therapies were approved in orphan indications last year, including drugs for Anthrax, Gaucher’s Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , ,

Navigating the Rare Disease World

Susan Ruediger

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage. This growth promises to improve the health of patients with debilitating and life-threatening disorders. Hoping to further the rare disease dialogue and relationship building opportunities, the 2013 Orphan Disease Forum will provide unique perspective on the orphan drug marketplace, regulatory considerations and much more. Operating within Read More >

Events  |  2 Comments  |  Email This Post
Tags: , , , , , , , ,

Rare Disease Day: Families and Advocacy Groups Drive Treatments for Rare Diseases

Gavin and Bella Today, we celebrate Rare Disease Day to recognize the path to treatments and cures is paved by families and caregivers working with advocacy groups, medical advisors, and dedicated researchers. Of the many people touched by and involved in the world of rare diseases, patients and their families are inarguably the most passionate advocates for rare disease research. When their disease-focused family foundations work together, pool their funds, and align their efforts, the results can be Read More >
Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

How Countries Can Boost Their Biotech Industry

Field

How can countries and regions boost the biotech industry within their borders? Working with several member companies, BIO developed a Global Policy Platform to serve as a roadmap for policymakers seeking to create an environment for the biotech industry to grow and prosper. These policy principles include four components: (i) research collaboration; (ii) intellectual property rights; (iii) regulatory approval; and (iv) market access. In addition, the Global Policy Platform includes best practices from around the Read More >

Corporate  |  1 Comment  |  Email This Post
Tags: , , , ,

BIO One-on-One Partnering Opens for BIO International Convention

Partnering

The 2013 BIO International Convention and BIO Business Forum is kicking in to full gear! And today is a big day! The BIO One-on-One Partnering System™ for the event has officially launched! This means that login credentials are being sent to registered participants, who can access the site to set up their profiles and send and accept meeting requests. We had a stellar year last year, where records were legitimately broken. So here’s to breaking new Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,